Originally published In Press as doi:10.1074/jbc.M111498200 on April 2, 2002
J. Biol. Chem., Vol. 277, Issue 23, 20911-20918, June 7, 2002
Targeted Gap Junction Protein Constructs Reveal
Connexin-specific Differences in Oligomerization*
Jayasri Das
Sarma,
Fushan
Wang, and
Michael
Koval
From the University of Pennsylvania School of Medicine, Department
of Physiology and Institute for Environmental Medicine,
Philadelphia, Pennsylvania 19104
Received for publication, December 3, 2001, and in revised form, March 22, 2002
 |
ABSTRACT |
To define further the mechanisms of gap junction
protein (connexin (Cx)) oligomerization without pharmacologic
disruption, we have examined the transport and assembly of connexin
constructs containing C-terminal di-lysine-based endoplasmic reticulum
(ER) (HKKSL) or ER-Golgi intermediate compartment (AKKFF) targeting sequences. By immunofluorescence microscopy, Cx43-HKKSL transiently transfected into HeLa cells showed a predominantly ER localization, although Cx43-AKKFF was localized to the perinuclear region of the
cell. Sucrose gradient analysis of Triton X-100-solubilized connexins
showed that either Cx43-HKKSL or Cx43-AKKFF expressed alone by HeLa
cells was maintained as an apparent monomer. In contrast to Cx43-HKKSL,
Cx32-HKKSL was maintained in the ER as stable hexamers, consistent with
the notion that Cx32 and Cx43 oligomerization occur in distinct
intracellular compartments. Furthermore, Cx43-HKKSL and Cx43-AKKFF
inhibited trafficking of Cx43 and Cx46 to the plasma membrane. The
inhibitory effect was because of the formation of mixed oligomers
between Cx43-HKKSL or Cx43-AKKF and wild type Cx43 or Cx46. Taken
together, these results suggest that Cx43-HKKSL and Cx43-AKKFF
recirculate through compartments where oligomerization occurs and may
be maintained as apparent monomers by a putative Cx43-specific quality
control mechanism.
 |
INTRODUCTION |
Prior to delivery to the plasma membrane and assembly into gap
junction channels, connexins are first assembled into hexameric hemichannels (1-5). Most assembly of oligomeric transmembrane proteins
occurs in the ER1 and is a
prerequisite for further transport along the secretory pathway (6).
However, connexin hemichannel assembly appears to be more complex,
because a number of intracellular compartments have been implicated in
hemichannel assembly, including the endoplasmic reticulum (ER) (7-9),
ER-Golgi intermediate compartment (ERGIC) (7), and trans-Golgi network
(TGN) (10-12). Defining the intracellular compartments involved in
connexin hemichannel assembly is further complicated by the potential
for multiple connexin trafficking pathways (10, 11, 13, 14) and the
possibility that different connexins, such as Cx32 and Cx43, may have
the potential to oligomerize in different compartments (4).
A number of different methods have been used to analyze the itinerary
of connexin assembly. Because reticulocyte lysates have the capacity to
oligomerize connexins translated in vitro, including Cx32
and Cx43 (9, 15-17), it has been suggested that connexin hemichannel
assembly occurs in the ER (9). In vitro translation has
provided some insights into amino acid determinants that might control
connexin oligomerization and the ability of different connexins to form
mixed (heteromeric) hemichannels. However, as is the case with many
in vitro systems, reticulocyte lysates lack many of the
structural elements and compartments present in the intact cell. Thus,
oligomerization by microsomes in vitro is not strong
evidence that a given process occurs in the ER. For instance, augmentation of microsomes with a liver Golgi fraction stimulates Cx32
oligomerization (18). Also, whereas Cx43 and Cx46 have the capacity to
intermix when translated in vitro, the ability of these two
connexins to intermix is dependent on cell phenotype and is controlled
at the level of Cx46 assembly (11).
Nonetheless, Kumar et al. (8) found by EM that baby hamster
kidney cells transfected to overexpress Cx32 had structures resembling
gap junction plaques localized to the ER, suggesting that Cx32 assembly
can occur there. In further support of the ER as a site for Cx32
hemichannel assembly, mutant forms of Cx32 that are not assembled and
that escape the ER are degraded by a putative quality control mechanism
(19).
Previous biochemical analysis of Triton X-100-solubilized extracts from
cells suggests that Cx43 hemichannel assembly occurs at the TGN
(10-12). Musil and Goodenough (12) used an extensive panel of
inhibitors, including BFA, carbonyl cyanide
p-chlorophenylhydrazone, 15 °C temperature block, and
Chinese hamster ovary cells with a temperature-sensitive block in
secretory transport to show that assembly of Cx43 into hexamers
required export from the ER. Monensin treatment also caused a 3-4-fold
reduction in Cx43 oligomerization in rat osteoblastic cells,
consistent with the TGN as the site for Cx43 hemichannel assembly (10).
We have also found that a Cx43-
-galactosidase fusion protein,
Cx43/
-gal, which inhibits native Cx43 trafficking to the TGN, also
inhibits Cx43 hemichannel assembly, again consistent with Cx43
hemichannel assembly at the TGN (11).
However, we also found that Cx43/
-gal formed sub-hexameric,
heteromeric complexes with native Cx43 and Cx46 in an aspect of the
Golgi apparatus, prior to the TGN (11). George et al. (7),
using cells transfected with connexin-aequorin chimeras, also found
subhexameric assembly intermediates enriched in purified ER, ERGIC, and
Golgi apparatus fractions. By fluorescence microscopy, most of the
Cx-aequorins appear to be concentrated in the perinuclear region of the
cell, with some cell surface expression (20). Cx26-, Cx32-, and
Cx43-aequorin all showed similar assembly profiles, with the Golgi
apparatus fraction containing the most connexin-aequorin hexamers in
each case (7). This, combined with our results using Cx43/
-gal,
raised the possibility that native connexin assembly intermediates,
such as dimers, might form in an aspect of the secretory pathway prior
to the TGN. However, whether these studies reflect intermediates
involved in the assembly of native connexins is not definitive, because
the constructs used were connexin fusion proteins containing either an
~23-kDa aequorin or 180-kDa
-galactosidase moiety at the extreme C
terminus. The potential pitfalls of adding a large protein motif to a
connexin on oligomerization was illustrated by Lauf et al.
(21) who showed that a red fluorescent protein (DsRed)-Cx43 fusion
protein was retained in an intracellular compartment which showed
partial co-localization with calnexin, due to oligomerization between DsRed domains to form SDS-resistant tetramers. However, when DsRed-Cx43 was co-expressed with native Cx43 or Cx43-EGFP, it was
transported to the plasma membrane where it formed heteromeric gap
junction channels. This suggests that DsRed-Cx43 and wt Cx43 might have the potential to interact in the ER or another early secretory compartment.
In order to investigate further connexin assembly in early secretory
compartments, we produced a series of connexin-based constructs
containing di-lysine targeting motifs to potentially localize them to
early intracellular compartments (22-25). Short di-lysine motifs,
oriented toward the cytosol at the extreme C terminus of a
transmembrane protein, enable ER retention by inhibiting clustering
into COP II-coated secretory vesicles (26, 27) and also enable
protein retrieval and by interacting with multiple components of COP
I-coated retrograde transport vesicles (28, 29). In contrast to
pharmacologic methods, such as BFA (30), which disrupt cell
compartmentation, this approach offers the ability to examine connexins
in relatively unperturbed early secretory compartments.
We found that connexin fusion proteins, Cx32-HKKSL and Cx43-HKKSL, were
retained in the ER consistent with their retention signals. When
expressed alone in cells, the targeted Cx43 constructs were retained as
monomers. In contrast, Cx32-HKKSL, which was also retained in the ER,
was assembled into hexamers suggesting that Cx32 and Cx43 hemichannel
assembly occur in distinct subcompartments. Furthermore, despite the
retention of Cx43-HKKSL and Cx43-AKKFF as monomers when expressed
alone, these constructs had the capacity to interact with compatible
native connexins. Thus, despite the trafficking of Cx43-HKKSL and
Cx43-AKKFF through intracellular compartments where oligomerization is
initiated, they are maintained as apparent monomers.
 |
MATERIALS AND METHODS |
Antisera and Reagents--
Rabbit anti-Cx43 (31) and anti-Cx46
(10) antisera were generated using His6-tagged C-terminal
tail constructs as described previously. Rabbit anti-Cx32, mouse
anti-calnexin, and anti-
-COP were from Zymed
Laboratories Inc. (South San Francisco, CA). Monoclonal anti-Cx43
was from Chemicon (Temecula, CA). Fluorescent and horseradish peroxidase-conjugated secondary antibodies were from Jackson
ImmunoResearch (West Grove, PA). Biomag particles coated with goat
anti-mouse IgG were from Polysciences (Warrington, PA). Triton X-100
was from Roche Diagnostics. Tissue culture reagents were from
Invitrogen. Unless otherwise specified, all other reagents were from Sigma.
Constructs, Transfection, and Immunofluorescence--
Tagged
constructs were produced by PCR amplification in a Stratagene
Robocycler (La Jolla, CA) using High Fidelity DNA polymerase (Roche
Diagnostics), starting with rat Cx43 or Cx32 cDNA as a template.
For the Cx43-based constructs, the sense primer was 5'-CGGGGTACCG AATTCCCCAG ACATGGGTGA CTGGA-3', and the antisense primers were either 5'-CCGCTCGAGT TAGAGTGACT TCTTGTGAAT CTCCAGGTCA TCAGGCC-3' (HKKSL) or 5'-GGCCTGATGA CCTGGAGATT GCTAAGAAGT TCTTCTAACT CGAGCGG-3' (AKKFF). Cx32-HKKSL was produced using 5'-CGGGGTACCG AATTCGAATG AGGCAGGATG AACTG-3' and 5'-CCGCTCGAGT TAGAGTGACT TCTTGTGGCA GGCTGAGCA TCGGTCGC-3' as the sense and antisense primers, respectively. The resulting PCR products were cut with KpnI and
XhoI, ligated into a pcDNA3 expression vector, and
transformed into bacterial stocks. DNA for transfection was purified
from bacteria using the Qiagen Maxiprep kit according to the
manufacturer's instructions. Prior to transfection, cDNA was
purified by EtOH precipitation.
HeLa cells were transiently transfected with either wild type or
modified connexin cDNA constructs using LipofectAMINE (Invitrogen) at 2 µg/ml DNA using LipofectAMINE/DNA ratios of either 3:1
(µl/µg) for 100-mm dishes or 4:1 (µl/µg) for 35-mm dishes and
analyzed 48 h after transfection. Transfection efficiencies using
this approach were typically greater than 70%. In some experiments, previously generated, stably transfected HeLa/Cx43myc and HeLa/Cx46 cells were transiently transfected in a manner comparable with wild
type HeLa cells.
For immunofluorescence, cells plated on glass cover slips were fixed
and permeabilized with MeOH/acetone (1:1), then washed 3× with PBS,
followed by PBS + 0.5% Triton X-100 and PBS + 0.5% Triton X-100 + 2%
heat-inactivated goat serum (PBS/GS). The cells were incubated with
primary antisera diluted into PBS/GS for 1 h, washed, and then
labeled with secondary antisera diluted into PBS/GS. The cells were
then washed with PBS, mounted into Mowiol, and visualized by
fluorescence microscopy using an Olympus X-70 microscope system with a
40× UPlanApo oil immersion objective (1.0 numerical aperture)
with the iris diaphragm partially closed to limit the contribution of
out of plane fluorescence and filter packs suitable for green (U-MWIBA
BP460-490 DM505 BA515-550) and red (U-MNG BP530-550 DM570 BA590-800+)
fluorescence. Images were acquired with a Hamamatsu Orca-1 CCD camera
and Image Pro image analysis software (Media Cybernetics, Silver
Spring, MD).
Protein Analysis--
The techniques outlined below have also
been described elsewhere (10, 11, 32). Cells were washed with PBS,
harvested into PBS containing protease inhibitors (10 mM
N-ethylmaleimide, 1 mM phenylmethylsulfonyl
chloride, 2 µg/ml leupeptin, and 1 µg/ml pepstatin) and phosphatase
inhibitors (1 mM NaVO4 and 10 mM
NaF), and then passed through a ball bearing homogenizer 100 times (10, 11). The homogenate was centrifuged at 500 × g for 5 min using a IEC CL3R centrifuge and then the resulting post-nuclear
supernatant was centrifuged at 100,000 × g for 30 min
using a Beckman TL-100 ultracentrifuge to obtain a membrane-enriched
pellet. To analyze total cell connexin expression, this pellet was
resuspended in SDS-PAGE sample buffer, resolved by electrophoresis,
transferred to polyvinylidene difluoride, and then detected by
immunoblot. Densitometric analysis of non-saturated films was performed
using the Kodak IDAS system (Eastman Kodak).
For detergent solubilization studies, the membrane-enriched pellet was
resuspended in PBS + inhibitors containing 1% Triton X-100 and then
incubated for 30 min at 4 °C. The sample was then centrifuged at
100,000 × g from 30 min and separated into Triton X-100-soluble supernatant and -insoluble pellet fractions. The soluble
and insoluble fractions were then resuspended into SDS-PAGE sample
buffer and assayed by immunoblot.
Co-immunopurification was done starting with the Triton X-100-soluble
fraction prepared as described above. Magnetic goat anti-mouse
IgG-coated particles were incubated with the Triton X-100-soluble
fraction for 2 h with mouse anti-Cx43 antisera in PBS containing
0.25% bovine serum albumin and 0.2% gelatin. The magnetic particles
were then added to the Triton X-100-soluble fraction, incubated for
2 h at 4 °C, and isolated using a ceramic magnet (Stratagene).
The particles were washed with cold PBS, resuspended in SDS-PAGE sample
buffer, and then analyzed by immunoblot.
Sucrose gradient fractionation was done using post-nuclear supernatants
solubilized in 1% Triton X-100 and incubated for 30 min at 4 °C.
The samples were then centrifuged at 100,000 × g for
30 min, and the resulting Triton X-100-soluble fraction was overlaid
onto a 5-20% sucrose gradient. The gradient was centrifuged at
148,000 × g for 16 h in a Sorvall Ultra Pro 80 centrifuge using an AH-650 swinging bucket rotor. Following
centrifugation, 0.5-ml fractions were collected from the bottom of the
centrifuge tube at 4 °C and then analyzed by immunoblot.
Preloading Assay--
The preloading dye transfer assay for gap
junction formation was done as described previously (32) with
modifications. Donor and acceptor HeLa cells were transiently
transfected using LipofectAMINE with 2 µg/ml either wt Cx43 or
Cx43-HKKSL or Cx43-AKKFF or simultaneously with 1 µg/ml wt Cx43 plus
1 µg/ml Cx43-HKKSL or 1 µg/ml wt Cx43 plus 1 µg/ml Cx43-AKKFF and
allowed to recover for 36 h. Donor cells were incubated overnight
at 37 °C in tissue culture medium containing 1 mg/ml Texas Red
dextran (Mr 10,000) as a non-transferable, endocytosed marker. The cells were then washed and incubated in minimum
Eagle's medium containing 10 µM calcein-AM (Molecular Probes) for 30 min at 37 °C to load the cytoplasm of donor cells with calcein. The donor cells were then washed, trypsinized, and then
mixed at a 1:10 ratio with unlabeled, trypsinized acceptor cells. The
cells were co-cultured for 5 h, and the specific transfer of
calcein from donor to acceptor cells was scored by fluorescence microscopy using a blinded coding system. Data were expressed as the
fraction of calcein-positive acceptor cells as calculated from at least
150 donor cell-acceptor cell interfaces from 2 to 4 independent experiments.
 |
RESULTS |
Retention of Di-lysine-targeted Cx43 Constructs--
Cx43-based
cDNA constructs containing two different di-lysine-based retention
motifs, Cx43-HKKSL and Cx43-AKKFF, were produced as described under
"Materials and Methods." To define the intracellular trafficking of
these constructs, Cx43-HKKSL and Cx43-AKKFF were transiently
transfected into HeLa cells and then examined by immunofluorescence microscopy. In contrast to wild type Cx43, which showed high levels of
transport to the cell surface (Fig. 1),
both Cx43-HKKSL and Cx43-AKKFF were preferentially retained in
intracellular compartments.

View larger version (84K):
[in this window]
[in a new window]
|
Fig. 1.
Targeted Cx43 constructs are retained in
intracellular compartments. HeLa cells transiently transfected
with either wild type Cx43 (a), Cx43-HKKSL (b),
or Cx43-AKKFF (c) were fixed, permeabilized, and then
immunostained with rabbit anti-Cx43 antibodies and Texas Red goat
anti-rabbit IgG. Wild type Cx43 showed punctate cell surface labeling,
whereas Cx43-HKKSL and Cx43-AKKFF were retained in intracellular
compartments, although Cx43-AKKFF occasionally showed a localization
pattern consistent with gap junction plaques (arrowhead).
Bar = 20 µM. d, membrane
preparations from HeLa cells transfected with either wild type Cx43
(lanes 1 and 2), Cx43-HKKSL (lanes 3 and 4), or Cx43-AKKFF lanes 5 and 6 were incubated in 1% Triton X-100 at 4 °C for 30 min and then
centrifuged at 100,000 × g to separate Triton
X-100-soluble (sol, lanes 1, 3, and 5)
and -insoluble fractions (ins, lanes 2, 4, and
6), which were resolved by SDS-PAGE and detected by
immunoblot. There were barely detectable levels (<8% total) of
Cx43-HKKSL present in the Triton X-100-insoluble fraction (lane
4), in contrast to cells expressing wild type Cx43 (lane
2) or Cx43-AKKFF (lane 6). Note the presence of 44- and
46-kDa phosphorylated species of wild type Cx43 in the Triton
X-100-insoluble fraction (lane 2) and the 40 + 42 kDa
Cx43-HKKSL doublet (lane 3). The position of the 48-kDa
marker is shown.
|
|
We used immunofluorescence co-localization to identify compartments
containing the targeted Cx43 constructs (Fig.
2). As shown in Fig. 2, Cx43-HKKSL showed
significant co-localization with the ER marker, calnexin. In contrast,
Cx43-AKKFF did not show significant overlap with the ER, consistent
with the "weaker" AKKFF ERGIC retention signal. However, both
Cx43-HKKSL and Cx43-AKKFF had significant overlap with
-COP (Fig.
2). Because di-lysine-based motifs interact with coatamer proteins (28,
29), this was not unexpected. However, because there are multiple
aspects of the Golgi apparatus that co-localize with
-COP in the
perinuclear region of the cell at the level of fluorescence microscopy
(33), we cannot precisely define the post-ER compartments containing Cx43-HKKSL and Cx43-AKKFF. Note also that the morphology of the
-COP-labeled perinuclear compartment was variable for wild type HeLa
cells, as well as transfected HeLa cells expressing di-lysine connexin
fusion proteins.

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 2.
Intracellular localization of targeted
Cx43 constructs. HeLa cells were transiently transfected with
Cx43-HKKSL (a-c and g-i) or Cx43-AKKFF
(d-f and j-l) fixed, and then double label
immunolabeled using mouse anti-Cx43 (a, d, g, and
j) and rabbit anti-calnexin (b and e)
or rabbit anti- -COP (h and k), which
were stained with Texas Red goat anti-mouse IgG and fluorescein
isothiocyanate goat anti-rabbit IgG secondary antibodies. Merged images
are shown in (c, f, i, and l). Cx43-HKKSL showed
extensive co-localization with the ER marker calnexin
(arrows). When compared with -COP, Cx43-HKKSL
showed partial co-localization (arrowheads), whereas
Cx43-AKKFF showed nearly complete co-localization with -COP.
Bar, 20 µm.
|
|
Cx43-AKKFF also occasionally assembled into gap junction plaques
localized to the plasma membrane, suggesting that there was some
Cx43-AKKFF transport through late elements of the secretory pathway. In
contrast, cells transfected with Cx43 HKKSL did not show detectable
Cx43-HKKSL at the cell surface by immunofluorescence. To assess further
the extent of Cx43 incorporation into plaques, we examined the
solubility of Cx43-HKKSL and Cx43-AKKFF in Triton X-100, because Cx43
assembled into gap junction plaques is not soluble in 1% Triton X-100
at 4 °C. As shown in Fig. 1d, wild type Cx43 showed both
Triton X-100-soluble and -insoluble fractions, where the Triton-soluble
fraction contained only the NP form of Cx43, and the Triton
X-100-insoluble fraction contained both non-phosphorylated and
phosphorylated forms of Cx43 (10, 11, 34). Consistent with the relative
strength of these retention signals, there was some Cx43-AKKFF in the
Triton X-100-insoluble fraction, whereas nearly all of the Cx43-HKKSL
was in the Triton X-100-soluble fraction. This was consistent with
functional studies that showed that HeLa cells expressing Cx43-AKKFF
were fairly well coupled as opposed to cells expressing Cx43-HKKSL (see below).
Neither Cx43-HKKSL nor Cx43-AKKFF showed phosphorylation to the P1 and
P2 forms observed for wild type Cx43. However, Cx43-HKKSL routinely
resolved as a doublet by gel electrophoresis (see also Fig. 6), with
the majority of the protein showing an apparent mass of 42 kDa
along with a minor 40-kDa band. Because Cx43-AKKFF showed predominantly
the 42-kDa band, this was suggestive of potential intracellular
phosphorylation (35-38). However, samples from Cx43-HKKSL-transfected HeLa cells treated with 2 units of calf intestinal alkaline phosphatase for 4 h at 37 °C (39) showed little change in the doublet
migration pattern (data not shown) suggesting that this was not the
case. The nature of the 40-kDa band is not clear at present. One
possibility is that this may represent a Cx43 cleavage product (19,
40).
Differential Oligomerization of Cx43-HKKSL and Cx32-HKKSL--
We
then examined the oligomerization of ER-retained Cx43 constructs by
sucrose gradient fractionation. As shown in Fig.
3a, the Triton X-100-soluble
fraction of wild type Cx43 showed the characteristic pattern of two
peaks, centered at 8-10% sucrose and 15-17% sucrose, which
correspond to monomeric and oligomerized Cx43, respectively. In
contrast, the same fraction isolated from HeLa cells expressing either
Cx43-HKKSL or Cx43-AKKFF alone showed only the monomer peak. There was
little, if any, oligomerized connexin present in these Triton
X-100-soluble fractions. Thus, there were no apparent intracellular
Cx43-HKKSL or Cx43-AKKFF oligomers, when they were the only connexin
expressed by HeLa cells.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Intracellular targeted Cx43 constructs
expressed alone by HeLa cells are monomeric. Post-nuclear
supernatants from HeLa cells transfected with wild type Cx43
(a), Cx43-HKKSL (b), or Cx43-AKKFF (c)
were solubilized in 1% Triton X-100 and then analyzed by sucrose
gradient fractionation as described under "Materials and Methods."
The peak at 5-11% sucrose corresponds to Cx43 monomers, whereas
oligomerized Cx43 sedimented at 13-20% sucrose (a).
Neither Cx43-HKKSL nor Cx43-AKKFF expressed alone by wt HeLa cells
showed stable intracellular oligomers when analyzed by sucrose gradient
fractionation.
|
|
Because it has been suggested that Cx32 hemichannels may be
oligomerized in the ER (8), we wanted to determine whether a Cx32-HKKSL
construct might be oligomerized. As shown in Fig. 4a, Cx32-HKKSL is retained in
the ER, showing a similar intracellular distribution to Cx43-HKKSL.
However, in contrast to Cx43-HKKSL, virtually all of the Cx32-HKKSL
expressed by HeLa cells resolved to a peak at 15% sucrose in the
gradient. This was due to oligomerization, because pretreatment with
SDS caused the Cx32-HHKSL peak to shift to a lighter sucrose density
fraction (Fig. 4b). Thus, Cx32-HKKSL and Cx43-HKKSL were
maintained in the ER in different states of oligomerization, suggesting
that Cx32 and Cx43 may oligomerize in distinct intracellular
compartments.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 4.
Cx32-HKKSL is ER-retained and
oligomerized. a, HeLa cells were transfected with
Cx32-HKKSL and then fixed, permeabilized, and then immunostained with
rabbit anti-Cx32 antibodies and Texas Red goat anti-rabbit IgG. Note
the immunofluorescence localization pattern similar to Cx43-HKKSL (see
Figs. 1 and 2). b, HeLa cells transfected with Cx32-HKKSL
were solubilized in 1% Triton X-100 in either the absence ( ) or
presence ( ) of 0.2% SDS and then analyzed by sucrose gradient
fractionation. In contrast to Cx43-HKKSL, Cx32-HKKSL was oligomerized
into SDS-sensitive complexes.
|
|
Targeted Cx43 Constructs Oligomerize with Cx46--
Despite the
fact that Cx43-HKKSL and Cx43-AKKFF were not oligomerized, our previous
results (11) showing oligomerization of Cx43/
-gal with wild type
connexins in a BFA-sensitive compartment raised the possibility that
the di-lysine-targeted constructs might also interact with wild type
connexins. We first examined whether this was the case using HeLa cells
stably transfected with Cx46 (HeLa/Cx46 cells). Cx43 and Cx46 are
compatible to form mixed gap junction channels in HeLa cells, and this
offered us the advantage of using two different antibodies to
simultaneously localize Cx43 and Cx46 in the same cell (11). As shown
in Fig. 5, wild type Cx43 and Cx46
co-localize predominantly in gap junction plaques, consistent with
co-assembly of these proteins into heteromeric gap junction channels.
However, transient transfection of either Cx43-HKKSL or Cx43-AKKFF into
HeLa/Cx46 cells caused Cx46 to be preferentially retained in
intracellular compartments that co-localized with the targeted Cx43
construct. The ER-retained Cx43-HKKSL was more effective at inhibiting
Cx46 transport to the cell surface than the ERGIC-retained Cx43-AKKFF
construct.

View larger version (127K):
[in this window]
[in a new window]
|
Fig. 5.
Targeted Cx43 constructs alter the
intracellular distribution of Cx46. HeLa/Cx46 cells were
transiently transfected with either wild type (wt) Cx43
(a-c), Cx43-HKKSL (d-f), or Cx43-AKKFF
(g-i). 48 h after transfection the cells were fixed,
permeabilized, and then double label immunostained using mouse
anti-Cx43 (a, d, and g) and rabbit anti-Cx46
(b, e, and h) which were detected using Texas Red
goat anti-mouse IgG and fluorescein isothiocyanate goat anti-rabbit IgG
as secondary antibodies. Merged images are shown in (c,
f, and i). HeLa/Cx46 cells expressing wild type
Cx43 showed Cx43 and Cx46 co-localized at the plasma membrane
(arrows). In contrast, expression of Cx43-HKKSL or
Cx43-AKKFF caused Cx46 to be retained in intracellular compartments
(arrowheads). Note the presence of Cx43-AKKFF co-localized
with Cx46 at the plasma membrane in some cells (arrow).
Bar, 10 µm.
|
|
We then defined the assembly intermediates involved in Cx46 retention
by targeted Cx43 constructs. By sucrose gradient fractionation, there
was good overlap between the migration pattern of the targeted Cx43
constructs and Cx46 (Fig. 6). This was
due to a direct interaction between Cx43-HKKSL or Cx43-AKKFF and Cx46,
because we could specifically co-immunoisolate Cx46 with anti-Cx43
antibodies from HeLa cells expressing both connexins. Thus, despite the
fact that Cx43-HKKSL or Cx43-AKKFF expressed alone in HeLa cells did
not form stable oligomers, these constructs had the capacity to
oligomerize with a wild type connexin. Also, consistent with
significant efflux of Cx43-AKKFF out of the ER as compared with
Cx43-HKKSL, more of the Cx43-AKKFF/Cx46 oligomers were present
as hexamers than was the case for Cx43-HKKSL/Cx46 oligomers. The
fractionation pattern for Cx43-HKKSL/Cx46 contained oligomers that
migrated in the region of the gradient between 10 and 14% sucrose,
consistent with the notion that there were stable subhexameric
oligomers formed between Cx43-HKKSL and Cx46. Furthermore, there were
Triton X-100-soluble Cx46 oligomers that migrated toward the bottom of the sucrose gradient isolated from cells co-expressing Cx46 and Cx43-HKKSL or Cx43-AKKFF. This was not observed for sucrose gradient profiles obtained from control HeLa/Cx46 cells (10) and may reflect
saturation of a putative quality control mechanism by the expression of
the targeted Cx43 constructs.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 6.
Co-assembly of targeted Cx43 constructs and
Cx46 into oligomeric complexes. a and b,
post-nuclear supernatants from HeLa/Cx46 cells transiently transfected
with either Cx43-HKKSL (a) or Cx43-AKKFF (b) were
solubilized in 1% Triton X-100 and then analyzed by sucrose gradient
fractionation as described under "Materials and Methods." The
dashed line ( ) corresponds to Cx46, and the solid
line ( ) corresponds to either Cx43-HKKSL (a) or
Cx43-AKKFF (b). c, membrane preparations from
HeLa/Cx46 cells transfected with either Cx43-HKKSL (lanes 1 and 4), Cx43-AKKFF (lanes 2 and 5), or
non-transfected controls (lanes 3 and 6) were
solubilized in 1% Triton X-100 and then incubated with mouse anti-Cx43
IgG and goat anti-mouse IgG-conjugated magnetic beads to magnetically
isolate targeted Cx43 constructs. The proteins were solubilized in
sample buffer, resolved by SDS-PAGE, and then immunoblotted using
rabbit antisera that recognize either Cx43 (lanes 1-3) or
Cx46 (lanes 4-6), which was then detected by enhanced
chemiluminescence using horseradish peroxidase-conjugated goat
anti-rabbit IgG. Note that Cx46 specifically co-immunoisolated with
Cx43-HKKSL and Cx43-AKKFF (lanes 4 and 5). Shown
are the migration positions for 93-, 48-, and 35-kDa markers.
|
|
Targeted Cx43 Constructs Oligomerize with Wild Type Cx43--
To
determine whether targeted Cx43 constructs could interact with Cx43, we
examined the effect of Cx43-HKKSL on the trafficking of a Myc
epitope-tagged Cx43 construct. As shown in Fig.
7, transfection of HeLa/Cx43myc cells
with wild type Cx43 did not inhibit the trafficking of Cx43myc to the
plasma membrane. In contrast, cells expressing Cx43-HKKSL retained
Cx43myc in an intracellular compartment that showed partial overlap
with the ER. Cx43-HKKSL also changed the assembly state of the Triton
X-100-soluble pool of Cx43myc. In control HeLa/Cx43myc cells, the
Triton X-100-soluble pool of Cx43myc showed a similar sucrose gradient
fractionation pattern to wild type Cx43 (Fig. 3a). In
contrast, co-expression of Cx43myc with Cx43-HKKSL caused the Triton
X-100-soluble pool of Cx43myc to shift to a mostly oligomerized
state.

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 7.
Cx43-HKKSL alters the intracellular
distribution and assembly of Cx43myc. HeLa/Cx43myc cells were
transiently transfected with either wild type Cx43 (a-c) or
Cx43-HKKSL (d-f). 48 h after transfection the cells
were fixed, permeabilized, and then double label immunostained using
mouse anti-Cx43 (a and d) and rabbit anti-Myc
(b and e) that were detected using Texas Red goat
anti-mouse IgG and fluorescein isothiocyanate goat anti-rabbit IgG as
secondary antibodies. Merged images are shown in c and
f. HeLa/Cx43myc cells expressing wild type (wt)
Cx43 showed Cx43 and Cx43myc labeling at the plasma membrane
(arrows) and, to a limited extent, intracellular
compartments (arrowheads). In contrast, expression of
Cx43-HKKSL caused Cx43myc to be retained in intracellular compartments
(arrowheads). g, post-nuclear supernatants from
HeLa/Cx43myc cells transiently transfected with either wild type Cx43
or Cx43-HKKSL were solubilized in 1% Triton X-100 and then
analyzed by sucrose gradient fractionation as described under
"Materials and Methods." The solid line ( )
corresponds to fractions containing Cx43myc from HeLa/Cx43myc cells
expressing wild type Cx43. The dashed line ( ) corresponds
to fractions containing Cx43myc from HeLa/Cx43myc cells expressing
Cx43-HKKSL. Note the shift in the Cx43myc peak from predominantly
monomers to predominantly oligomers when co-expressed with Cx43-HKKSL.
Bar, 10 µm.
|
|
We then examined the effect of Cx43-HKKSL and Cx43-AKKFF on
Cx43-mediated gap junctional communication using the preloading assay.
HeLa cells were transiently transfected with either wild type Cx43,
Cx43-AKKFF, or Cx43-HKKSL, and the specific transfer of calcein from
double-labeled donor cells to unlabeled acceptor cells was assessed by
fluorescence microscopy. As a quantitative measure for dye transfer, a
coupling index was measured, which is the fraction of donor-acceptor
interfaces that mediated specific calcein dye transfer between adjacent
cells. The coupling index for cells transiently transfected with wild
type Cx43 was high 0.53 ± 0.04 (n = 875 donor/acceptor interfaces), indicating that wild type Cx43 formed
functional gap junction channels. Cx43-AKKFF-expressing cells also
showed high levels of gap junction formation (0.39 ± 0.07 (n = 602 interfaces)), consistent with the observation that some HeLa cells transfected with Cx43-AKKFF alone showed apparent
gap junction plaques (Figs. 1 and 2). Cells transiently expressing
Cx43-HKKSL alone showed low levels of gap junction channel activity
using the preloading assays (0.19 ± 0.05 (n = 423 interfaces)), 3-4-fold less than cells transiently transfected with
wild type Cx43. Transiently transfecting HeLa cells with twice as much
Cx43-HKKSL cDNA (4 µg/ml) did not significantly increase the
coupling index (0.25 ± 0.05 (n = 162 interfaces)). Although the ability to detect gap junction formation by
cells transfected with Cx43-HKKSL is likely due to the sensitivity of the preloading assay, this does suggest that there are low levels of
Cx43-HKKSL transport to late secretory compartments and the plasma membrane.
Gap junctional communication was then measured with the preloading
assay using HeLa cells stably transfected with wild type Cx43
(HeLa/Cx43) and transiently transfected with Cx43-HKKSL cDNA. Cells
stably expressing wild type Cx43 showed the expected high levels of
coupling with the preloading assay (0.79 ± 0.08 (n = 442 interfaces)). HeLa/Cx43 cells transfected with
0.5 or 1 µg/ml Cx43-HKKSL showed little, if any, effect on gap
junctional communication, with coupling indices of 0.83 ± 0.04 (n = 243 interfaces) and 0.79 ± 0.11 (n = 196 interfaces), respectively. In contrast,
HeLa/Cx43 cells transiently transfected with 2 µg/ml Cx43-HKKSL
cDNA showed an ~10% decrease in gap junctional communication as
compared with HeLa/Cx43 cells, with a coupling index of 0.69 ± 0.03 (n = 159 interfaces). This modest decrease was
statistically significant (p < 0.05), consistent with
the ability of Cx43-HKKSL to interact with non-tagged, wild type Cx43.
Whether this low level of inhibition has physiological consequences
seems less likely and remains to be determined.
 |
DISCUSSION |
In this study, we found that the HKKSL di-lysine
retention/retrieval motif at the extreme C terminus of Cx43 and Cx32
was able to retain these connexins in the ER, in the case of HKKSL, or
perinuclear region of the cell, in the case of AKKFF. By using these
retention motifs, Cx32 and Cx43 constructs localized to early secretory
compartments showed differential states of oligomerization, where
Cx32-HKKSL was oligomerized into hexamers, whereas intracellular pools
of Cx43-HKKSL and Cx43-AKKFF were maintained as apparent monomers.
However, Cx43-HKKSL and Cx43-AKKFF were still able oligomerize with
wild type Cx43 and Cx46 when co-expressed in the same cell.
The observation that Cx32-HKKSL and Cx43-HKKSL were in different
assembly states, despite both being preferentially localized to the ER,
is consistent with the notion that there are at least two connexin
oligomerization pathways (Fig. 8) (4).
Based on dendrogram analysis of amino acid sequences, Cx32 is a
-class connexin, and Cx43 is an
-class connexin (2). Whether the results presented here can be generalized to a model where
oligomerization of
-connexins occurs in the ER and oligomerization
of
-connexins occurs in post-ER compartments remains to be
determined. However, because mixed oligomerization of Cx43 and another
-connexin, Cx46, depends on cell type (11, 41) and because Cx46
retained in the TGN is in an apparent monomeric form (10), there may in
fact be more than two connexin oligomerization pathways. This notion of
multiple pathways is also suggested by differential sorting of Cx26 and
Cx32 (7, 42) and by the effect of multiple inhibitors on Cx43 transport
to the plasma membrane (13).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 8.
Models for oligomerization of
di-lysine-retained connexins. a, Cx32-HKKSL is
oligomerized in the ER retained in early secretory compartments using
the ER retrieval pathway. b, in contrast to Cx32-HKKSL,
Cx43-HKKSL (or Cx43-AKKFF) oligomerization is initiated in later
secretory compartments. In this model, free monomers are preferentially
retrieved to the ER. However, once oligomerization is initiated, it may
either progress further to generate hemichannels or oligomers might be
retrieved to the ER and disassembled. c, when co-expressed
with wild type connexins (wt Cx) (dark ovals),
this helps drive oligomerization. However, heteromeric oligomers also
have the capacity to be retrieved to the ER as part of a futile
trafficking cycle which, in turn, may enrich the oligomer content of
the intracellular connexin pool. The intracellular compartments
involved in each of these processes in this model are denoted by the
lines above, although there are alternative
possibilities.
|
|
Whereas this approach examines the behavior of connexin fusion
proteins, these have only five added amino acids to the C terminus, which is less likely to be disruptive than the addition of larger protein moieties, such as
-galactosidase (11). Consistent with this,
ER or ERGIC morphology was not perturbed by HKKSL- or AKKFF-tagged connexins. Also, Cx43-HKKSL was not significantly present in a Triton
X-100-insoluble fraction (Fig. 1), suggesting that it was not
misfolded. In addition, the level of Cx43-AKKFF in the Triton X-100-insoluble pool was consistent with the presence of Cx43-AKKFF assembled into gap junction plaques. Using di-lysine-tagged connexins also offers the advantage that pharmacologic agents or other approaches were not required to interfere with connexin trafficking. Thus, we are
likely to be examining the behavior of Cx32-HKKSL and Cx43-HKKSL in
cells which have normally formed and functioning secretory compartments.
Defining the post-ER compartments involved in Cx43 oligomerization is
somewhat complex, particularly because there are seven distinct stacks
of the Golgi apparatus, including the ERGIC and TGN that are in close
apposition in the perinuclear region of the cell (33). Given previous
work showing that Cx43/
-gal inhibits wild type Cx43 trafficking by
forming a heterodimer with wild type Cx43 in a BFA-sensitive
perinuclear compartment (11), Cx43 oligomerization may be initiated
prior to the medial Golgi apparatus and then completed in the TGN as
part of a putative multistep process for hemichannel formation. Whether
this is the case is still an open question, although there is
precedence for oligomerization events in the Golgi apparatus including
budding of corona viruses from the Golgi apparatus (43) and the kin
recognition model for localization of Golgi resident proteins
(44-47).
Analysis of cells expressing wild type Cx43 indicates that there are
three predominant pools of Cx43 as follows: monomeric intracellular
Cx43, hexameric intracellular Cx43, and Cx43 assembled into gap
junction channels at the plasma membrane (10, 12, 48). This suggests
that there are two rate-limiting steps in Cx43 oligomerization, namely
initiation of Cx43 oligomerization and delivery of Cx43 hemichannels to
the cell surface for assembly into gap junction channels. Given that
Cx43-HKKSL and Cx43-AKKFF hetero-oligomerize with wild type Cx43 and
Cx46, the targeted Cx43 constructs must have access to intracellular
compartments where oligomerization is initiated (Fig. 8). However, this
is in apparent conflict with the observation that these
di-lysine-targeted Cx43 constructs are maintained as apparent monomers
when expressed alone by HeLa cells. One possibility is that initiation
of oligomerization may be less efficient for Cx43-HKKSL and Cx43-AKKFF
due the di-lysine motif itself, although Cx32-HKKSL oligomerization was
fairly complete suggesting that this is not the case.
Cx43-HKKSL and Cx43-AKKFF are subject to two competing processes,
namely ER retrieval and initiation of oligomerization (Fig. 8). Single
Cx43-HKKSL molecules can be retrieved through the di-lysine motif (22,
23); however, oligomerization requires two or more Cx43-HKKSL molecules
to interact. Given this, ER retrieval is likely to be the preferred
pathway for cells expressing Cx43-HKKSL alone, if the level of
Cx43-HKKSL monomers available for oligomerization is relatively low.
Because cells expressing Cx43-HKKSL and Cx43-AKKFF alone showed
intercellular communication using the preloading assay, these connexins
do oligomerize on their own. However, stable intracellular hemichannels
were not detected when cells expressed Cx43-HKKSL or Cx43-AKKFF alone,
consistent with low levels of oligomerization compared with wild type
connexins. Once assembled into gap junction plaques at the plasma
membrane, the turnover of di-lysine-targeted Cx43 constructs is likely
to be regulated independently from the ER retention pathways, instead
using previously described internalization pathways used for wild type
Cx43 (49, 50).
In contrast, when co-expressed with wild type connexins that are
readily oligomerizing, hetero-oligomerization of Cx43-HKKSL and wild
type connexins can more effectively compete with ER retrieval of
monomeric Cx43-HKKSL. This process also could be enhanced by repeated
iterations of hetero-oligomers between the ER and post-ER compartments
because mixed oligomers with wild type and di-lysine-targeted Cx43 are
likely to undergo a futile cycle of recycling between the ER and
post-ER compartments and thus stabilize the intracellular oligomer pool
(Fig. 8c). A similar argument can be made for
Cx43-AKKFF.
Cx43myc/Cx43-HKKSL and Cx46/Cx43-AKKFF formed hetero-oligomers with a
sucrose gradient migration pattern most consistent with hexamers. In
both of these cases, the intracellular distribution of these connexins
was in a compartment that appeared to be distinct from the ER. In
contrast, Cx46 and Cx43-HKKSL, which were more localized to the ER at
the level of immunofluorescence oligomerized into subhexameric
heteromers. The difference in oligomerization state of
Cx43myc/Cx43-HKKSL and Cx46/Cx43-HKKSL might reflect the relative
stability of homomeric Cx43 hemichannels, as compared with heteromeric
Cx43/Cx46 hemichannels (11, 51). Alternatively, subhexameric
Cx46/Cx43-HKKSL oligomers may be more effectively retained in earlier
secretory compartments than Cx46/Cx43-AKKFF and Cx43myc/Cx43-HKKSL.
Stable subhexameric oligomers have also been shown to be formed by
Cx43-aequorin (7). However, in their system, Cx32- and Cx43-aequorin
chimeras showed similar oligomerization profiles, which initiated in
the ER/ERGIC and differed from our observations showing that Cx32-HKKSL
and Cx43-HKKSL were in different states of oligomerization. Whether the
difference between aequorin and di-lysine connexin chimeras can be
attributed to the aequorin moiety remains to be determined. One
possibility is that constructs containing a large protein domain, such
as aequorin or
-galactosidase, might have near normal rates for
initiation of oligomerization and slower rates for completion of
oligomerization compared with rates for unmodified connexins, if we
assume that initiation and completion of oligomerization are separable
events. Whether this is the case remains to be determined.
Di-lysine motifs also help retain proteins in the ER in addition to
retrieval from distal secretory compartments. For instance, the
di-phenylalanine (FF) domain of the AKKFF motif promotes escape of
ERGIC-35 from the ER and enables this protein to recycle between the ER
and ERGIC (27). In contrast, a mutant form of ERGIC-35 containing an
AKKAA motif now rarely escapes the ER (26). Given the possibility that
the di-lysine motif may enhance ER retention, in addition to retrieval,
hetero-oligomerization of di-lysine targeted Cx43 with wild type Cx43
may facilitate trafficking of Cx43-HKKSL and Cx43-AKKFF to post-ER
secretory compartments, because formation of mixed oligomers could
reduce the effectiveness of the di-lysine retention motif. This would
mimic a natural role for di-lysine retention signals, because cells use
protein oligomerization to mask ER retention motifs in order to
regulate assembly of some multimeric proteins, such as the IgE receptor
(52).
This suggests an alternative model, where the level of wild type Cx43
expression in the ER itself might be high enough to initiate
hetero-oligomerization with Cx43-HKKSL or Cx43-AKKFF and subsequent
escape from the ER. However, transfection with high levels of
Cx43-HKKSL (4 µg/ml) did not increase the level of gap junction
formation, arguing against the notion that increased levels of
Cx43-HKKSL expression can drive ER oligomerization. The notion of Cx43
assembly at the ER was also suggested by Lauf et al. (21),
who showed that DsRed-Cx43 expressed alone by HeLa cells aggregated and
was retained in a perinuclear compartment that partially co-localized
with the ER marker calnexin by immunofluorescence microscopy.
Co-expression with wild type Cx43 enabled DsRed-Cx43 to be further
transported along the secretory pathway, due to the formation of
DsRed-Cx43/wild type Cx43 hetero-oligomers. Although the initiation of
oligomerization involving DsRed-Cx43 may occur in the ER, it is also
possible that DsRed can escape from the ER, is misfolded, and then
retrieved to the ER for degradation, as is the case for some misfolded
Cx32 mutants (19) and other misfolded proteins (53-55). Consistent
with this, DsRed-Cx43 was only localized to a subset of the ER, as
opposed to Cx43-HKKSL that showed extensive overlap with calnexin in a
compartment that resembled unperturbed ER. Results obtained with
DsRed-Cx43 are also complicated by the ability of DsRed to oligomerize
on its own, a point of concern when analyzing connexin chimeras with
-galactosidase (11) and aequorin (7).
Our results are also consistent with the possibility that partially
oligomerized Cx43-HKKSL or Cx43-AKKFF is retrieved to the ER and then
actively disassembled by a putative quality control apparatus or set of
chaperones. The idea of connexin chaperones stems from observations
that Cx43 and Cx46 hemichannel assembly occurs in post-ER compartments
(10-12). In order for this to occur, monomeric Cx43 (and Cx46) must
remain stably integrated in the membrane of the ER and other secretory
compartments. Because charged amino acid residues that normally line
the aqueous gap junction channel pore are likely to be exposed to the
hydrophobic core of the lipid bilayer when connexins are monomeric, it
seems plausible that putative transmembrane chaperones may exist to
shield these charged residues. To date, such chaperones have not been
identified; however, our results with targeted Cx43 constructs are
consistent with this possibility. Whether this is the case will require
identifying components of this potential quality control pathway.
 |
ACKNOWLEDGEMENTS |
We thank Elliot Hertzberg, Paul Lampe, and
Cecilia Lo for helpful discussions and Michael Beers for a critical
reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by an American Heart Association
grant-in-aid and National Institutes of Health Grant GM61012 (to M. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Physiology,
University of Pennsylvania School of Medicine, B-400 Richards Bldg./6085, 3700 Hamilton Walk, Philadelphia, PA 19104. Tel.: 215-898-9096; Fax: 215-573-5851; E-mail:
mkoval@mail.med.upenn.edu.
Published, JBC Papers in Press, April 2, 2002, DOI 10.1074/jbc.M111498200
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic
reticulum;
ERGIC, ER-Golgi intermediate compartment;
Cx, connexin;
TGN, trans-Golgi network;
BFA, brefeldin A;
PBS, phosphate-buffered
saline;
GS, goat serum;
wt, wild type;
COP, coatomer protein.
 |
REFERENCES |
| 1.
|
Simon, A. M.,
and Goodenough, D. A.
(1998)
Trends Cell Biol.
8,
477-483[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Kumar, N. M.,
and Gilula, N. B.
(1996)
Cell
84,
381-388[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Goodenough, D. A.,
Goliger, J. A.,
and Paul, D. L.
(1996)
Annu. Rev. Biochem.
65,
475-502[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Yeager, M.,
Unger, V. M.,
and Falk, M. M.
(1998)
Curr. Opin. Struct. Biol.
8,
517-524[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Kelsell, D. P.,
Dunlop, J.,
and Hodgins, M. B.
(2001)
Trends Cell Biol.
11,
2-6[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Hammond, C.,
and Helenius, A.
(1994)
J. Cell Biol.
126,
41-52[Abstract/Free Full Text]
|
| 7.
|
George, C. H.,
Kendall, J. M.,
and Evans, W. H.
(1999)
J. Biol. Chem.
274,
8678-8685[Abstract/Free Full Text]
|
| 8.
|
Kumar, N. M.,
Friend, D. S.,
and Gilula, N. B.
(1995)
J. Cell Sci.
108,
3725-3734[Abstract]
|
| 9.
|
Falk, M. M.,
Kumar, N. M.,
and Gilula, N. B.
(1994)
J. Cell Biol.
127,
343-355[Abstract/Free Full Text]
|
| 10.
|
Koval, M.,
Harley, J. E.,
Hick, E.,
and Steinberg, T. H.
(1997)
J. Cell Biol.
137,
847-857[Abstract/Free Full Text]
|
| 11.
|
Das Sarma, J.,
Meyer, R. A.,
Wang, F.,
Abraham, V., Lo, C.,
and Koval, M.
(2001)
J. Cell Sci.
114,
4013-4024[Medline]
[Order article via Infotrieve]
|
| 12.
|
Musil, L. S.,
and Goodenough, D. A.
(1993)
Cell
74,
1065-1077[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Paulson, A. F.,
Lampe, P. D.,
Meyer, R. A.,
TenBroek, E.,
Atkinson, M. M.,
Walseth, T. F.,
and Johnson, R. G.
(2000)
J. Cell Sci.
113,
3037-3049[Abstract]
|
| 14.
|
VanSlyke, J. K.,
and Musil, L. S.
(2000)
Methods
20,
156-164[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Zhang, J. T.,
Chen, M.,
Foote, C. I.,
and Nicholson, B. J.
(1996)
Mol. Biol. Cell
7,
471-482[Abstract]
|
| 16.
|
Ahmad, S.,
Iriondo, J. D.,
and Evans, W. H.
(1998)
Biochem. Soc. Trans.
26,
S304[Medline]
[Order article via Infotrieve]
|
| 17.
|
Falk, M. M.,
Buehler, L. K.,
Kumar, N. M.,
and Gilula, N. B.
(1997)
EMBO J.
16,
2703-2716[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Ahmad, S.,
Diez, J. A.,
George, C. H.,
and Evans, W. H.
(1999)
Biochem. J.
339,
247-253[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
VanSlyke, J. K.,
Deschenes, S. M.,
and Musil, L. S.
(2000)
Mol. Biol. Cell
11,
1933-1946[Abstract/Free Full Text]
|
| 20.
|
Martin, P. E.,
George, C. H.,
Castro, C.,
Kendall, J. M.,
Capel, J.,
Campbell, A. K.,
Revilla, A.,
Barrio, L. C.,
and Evans, W. H.
(1998)
J. Biol. Chem.
273,
1719-1726[Abstract/Free Full Text]
|
| 21.
|
Lauf, U.,
Lopez, P.,
and Falk, M. M.
(2001)
FEBS Lett.
498,
11-15[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Teasdale, R. D.,
and Jackson, M. R.
(1996)
Annu. Rev. Cell Dev. Biol.
12,
27-54[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Pelham, H. R.
(1995)
Curr. Opin. Cell Biol.
7,
530-535[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Hauri, H. P.,
Kappeler, F.,
Andersson, H.,
and Appenzeller, C.
(2000)
J. Cell Sci.
113,
587-596[Abstract]
|
| 25.
|
Cosson, P.,
and Letourneur, F.
(1995)
Cold Spring Harbor Symp. Quant. Biol.
60,
113-117[Medline]
[Order article via Infotrieve]
|
| 26.
|
Andersson, H.,
Kappeler, F.,
and Hauri, H. P.
(1999)
J. Biol. Chem.
274,
15080-15084[Abstract/Free Full Text]
|
| 27.
|
Kappeler, F.,
Klopfenstein, D. R.,
Foguet, M.,
Paccaud, J. P.,
and Hauri, H. P.
(1997)
J. Biol. Chem.
272,
31801-31808[Abstract/Free Full Text]
|
| 28.
|
Cosson, P.,
and Letourneur, F.
(1994)
Science
263,
1629-1631[Abstract/Free Full Text]
|
| 29.
|
Dogic, D.,
Dubois, A.,
de Chassey, B.,
Lefkir, Y.,
and Letourneur, F.
(2001)
Eur. J. Cell Biol.
80,
151-155[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Lippincott-Schwartz, J.,
Yuan, L. C.,
Bonifacino, J. S.,
and Klausner, R. D.
(1989)
Cell
56,
801-813[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Civitelli, R.,
Beyer, E. C.,
Warlow, P. M.,
Robertson, A. J.,
Geist, S. T.,
and Steinberg, T. H.
(1993)
J. Clin. Invest.
91,
1888-1896[Medline]
[Order article via Infotrieve]
|
| 32.
|
Koval, M.,
Geist, S. T.,
Westphale, E. M.,
Kemendy, A. E.,
Civitelli, R.,
Beyer, E. C.,
and Steinberg, T. H.
(1995)
J. Cell Biol.
130,
987-995[Abstract/Free Full Text]
|
| 33.
|
Marsh, B. J.,
Mastronarde, D. N.,
Buttle, K. F.,
Howell, K. E.,
and McIntosh, J. R.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
2399-2406[Abstract/Free Full Text]
|
| 34.
|
Musil, L. S.,
and Goodenough, D. A.
(1990)
Curr. Opin. Cell Biol.
2,
875-880[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Laird, D. W.,
Castillo, M.,
and Kasprzak, L.
(1995)
J. Cell Biol.
131,
1193-1203[Abstract/Free Full Text]
|
| 36.
|
Puranam, K. L.,
Laird, D. W.,
and Revel, J. P.
(1993)
Exp. Cell Res.
206,
85-92[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Cruciani, V.,
and Mikalsen, S. O.
(1999)
Exp. Cell Res.
251,
285-298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Crow, D. S.,
Beyer, E. C.,
Paul, D. L.,
Kobe, S. S.,
and Lau, A. F.
(1990)
Mol. Cell. Biol.
10,
1754-1763[Abstract/Free Full Text]
|
| 39.
|
Laird, D. W.,
Puranam, K. L.,
and Revel, J. P.
(1991)
Biochem. J.
273,
67-72[Medline]
[Order article via Infotrieve]
|
| 40.
|
VanSlyke, J. K.,
and Musil, L. S.
(2002)
J. Cell Biol.
157,
381-394[Abstract/Free Full Text]
|
| 41.
|
Abraham, V.,
Chou, M. L.,
DeBolt, K. M.,
and Koval, M.
(1999)
Am. J. Physiol.
276,
L825-L834[Medline]
[Order article via Infotrieve]
|
| 42.
|
Diez, J. A.,
Ahmad, S.,
and Evans, W. H.
(1999)
Eur. J. Biochem.
262,
142-148[Medline]
[Order article via Infotrieve]
|
| 43.
|
Weisz, O. A.,
Swift, A. M.,
and Machamer, C. E.
(1993)
J. Cell Biol.
122,
1185-1196[Abstract/Free Full Text]
|
| 44.
|
Munro, S.
(1995)
EMBO J.
14,
4695-4704[Medline]
[Order article via Infotrieve]
|
| 45.
|
Nilsson, T.,
Rabouille, C.,
Hui, N.,
Watson, R.,
and Warren, G.
(1996)
J. Cell Sci.
109,
1975-1989[Abstract]
|
| 46.
|
Nilsson, T.,
Slusarewicz, P.,
Hoe, M. H.,
and Warren, G.
(1993)
FEBS Lett.
330,
1-4[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Nilsson, T.,
Hoe, M. H.,
Slusarewicz, P.,
Rabouille, C.,
Watson, R.,
Hunte, F.,
Watzele, G.,
Berger, E. G.,
and Warren, G.
(1994)
EMBO J.
13,
562-574[Medline]
[Order article via Infotrieve]
|
| 48.
|
Musil, L. S.,
and Goodenough, D. A.
(1991)
J. Cell Biol.
115,
1357-1374[Abstract/Free Full Text]
|
| 49.
|
Jordan, K.,
Chodock, R.,
Hand, A. R.,
and Laird, D. W.
(2001)
J. Cell Sci.
114,
763-773[Abstract]
|
| 50.
|
Jordan, K.,
Solan, J. L.,
Dominguez, M.,
Sia, M.,
Hand, A.,
Lampe, P. D.,
and Laird, D. W.
(1999)
Mol. Biol. Cell
10,
2033-2050[Abstract/Free Full Text]
|
| 51.
|
Berthoud, V. M.,
Montegna, E. A.,
Atal, N.,
Aithal, N. H.,
Brink, P. R.,
and Beyer, E. C.
(2000)
Eur. J. Cell Biol.
80,
11-19
|
| 52.
|
Letourneur, F.,
Hennecke, S.,
Demolliere, C.,
and Cosson, P.
(1995)
J. Cell Biol.
129,
971-978[Abstract/Free Full Text]
|
| 53.
|
Kamhi-Nesher, S.,
Shenkman, M.,
Tolchinsky, S.,
Fromm, S. V.,
Ehrlich, R.,
and Lederkremer, G. Z.
(2001)
Mol. Biol. Cell
12,
1711-1723[Abstract/Free Full Text]
|
| 54.
|
Plemper, R. K.,
and Wolf, D. H.
(1999)
Trends Biochem. Sci.
24,
266-270[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Caldwell, S. R.,
Hill, K. J.,
and Cooper, A. A.
(2001)
J. Biol. Chem.
276,
23296-23303[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg 